Stocks and Investing
Stocks and Investing
Thu, November 4, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mike Matson Maintained (ATRC) at Strong Buy with Increased Target to $92 on, Nov 4th, 2021
Mike Matson of Needham, Maintained "AtriCure, Inc." (ATRC) at Strong Buy with Increased Target from $90 to $92 on, Nov 4th, 2021.
Mike has made no other calls on ATRC in the last 4 months.
There are 2 other peers that have a rating on ATRC. Out of the 2 peers that are also analyzing ATRC, 1 agrees with Mike's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Suraj Kalia of "Oppenheimer" Downgraded from Buy to Hold on, Thursday, August 5th, 2021
This is the rating of the analyst that currently disagrees with Mike
- William Plovanic of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $120 on, Thursday, August 5th, 2021
Contributing Sources